<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Market Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Market Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1001010T0&amp;denomIds=10.1.1&amp;selectedTab=summary">Tiaprofenic acid</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>13</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>1032</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>18.06</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1001010T0AAACAC&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Tiaprofenic acid 300mg tablets : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1306010V0&amp;denomIds=13.6.1&amp;selectedTab=summary">Tretinoin</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Topical preparations for acne</td>
      <td>146</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>16.17</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1306010V0AAAEAE&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Tretinoin 0.025% cream : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601023AF&amp;denomIds=6.1.2&amp;selectedTab=summary">Linagliptin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>126</td>
      <td>Other antidiabetic drugs</td>
      <td>1303</td>
      <td>0.10</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.11</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601023AFAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Linagliptin 2.5mg / Metformin 1g tablets : 99</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601023AFAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Linagliptin 2.5mg / Metformin 850mg tablets : 27</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0407010P0&amp;denomIds=4.7.1&amp;selectedTab=summary">Nefopam hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>464</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>3733</td>
      <td>0.12</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>6.79</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0407010P0AAABAB&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Nefopam 30mg tablets : 464</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1104020B0&amp;denomIds=11.4.2&amp;selectedTab=summary">Antazoline</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Other anti-inflammatory preparations</td>
      <td>50</td>
      <td>0.20</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>6.76</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1104020B0AAACAC&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Antazoline 0.5% / Xylometazoline 0.05% eye drops : 10</a></div></td></tr></tbody></table>

        <h2>Prescribing where Market Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0106020M0&amp;denomIds=1.6.2&amp;selectedTab=summary">Senna</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>252</td>
      <td>Stimulant laxatives</td>
      <td>1317</td>
      <td>0.19</td>
      <td>0.55</td>
      <td>0.14</td>
      <td>-2.60</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIvUlEQVR4nO2dfbAXVRnHP+eKhJigpSmmdoQx09SuYSEijf4DOHslokwrJgsYMk1Js1hNG5rKFp2IkXwZfAmpfKEuKHIopml0AgLJfAl8GV9wTSwjFcxKyuj0x3Nu/O4NkHvZ/e1vd5/PzJnffZnZ77P37nfP2XOe86zx3qMoSj1oKzoARVGahxpeUWqEGl5RaoQaXlFqhBpeUWqEGl5RaoQaXlFqhBpeUWqEGl5RaoQaXlFqRPkMb4zmAitKH+lXdABKObCxGwx8GPgQcCxwMHAgsA3YCmwCNgBPAQ8A69Mk2lZMtMrOMKXbPGOMx3tTdBh1wMbuMOAs4ExgGPAb4EFgHfAn4GVklDgAuQEMRW4GJwPvA54AVgMrgVVpEr3e5FNQeqCGV7phY/cO4OPAp4FDgYXA3cDDaRL9pxfH6QccB4wERgOnAi8C94W2Kk2if2QbvfJWqOEVbOwOAsYDHwOOBxYBtwMPpkmUyQViY2eAo4HTgNOBU4AUuB+5AaxOk+iNLLSUnaOGryk2dkcCExCTvxtYAtwDrGjGs3e4ARyLmP90YAQy9L8DWJYm0Zt5x1BH1PA1wsbuGOCTwMTwo8XIcP3RrHryvmJj1x8YA0xCJgavB25Kk+ivRcZVNdTwFcfG7ijgbMTo/wTuAhalSbSh0MB2QZgsnI5MGF4DzNMePxvU8BXExm4/4BxgKvA2xOQL0yR6ttDAeomN3aHAt5Dh/hfSJFpVcEilRw1fEcIz8QjE5GORofotaRI9UmhgGWBjNwK4Bfgl8HWd3e87aviSY2M3EFlCuwB4HZgHdFZtxtvGbgDwTWAccHaaRE8WHFIpUcOXFBu7YcD5yHOuA65Pk2hdsVHlj43dOOAGpKe/veh4yoYavmTY2B0HXA4MB64DbkuT6LVio2ouYVLvTuBxYHrVRjN5ooYvCTZ27wGuAj4QPhemSfTvYqMqDhu7vZEJvbHAWWkSPVNwSKVADd/ihGf0K5BZ9+8A83VTynZs7DqAuUhPv6ToeFodNXwLY2N3JvA9JNX122kS/a3gkFoSG7uhwM+AXwBX6g1x56jhW5BwAc8BBgPnp0n0WMEhtTw2dvsg2XmHA59Kk+gvBYfUkqjhW4hw0X4NOBcZxt9RdMprmQi5CFORv+GkNIkeKDiklkMN3wKEC3U8MAtYBszUHPK+Y2N3ErLbbw5wg940t6OGLxAbu72ADuAbSEGJy9Mk+n2xUVUDG7t3AguAfwHTdIgvqOELwMZuCDJsnwKsB65Kk+i3xUZVPcLI6YvApcCFaRK5gkMqHDV8k7CxOxCpJHMOcBgy5Lw5TaIXCg2sBtjYHQ38CPgdcGmaRH8vOKTCUMPnSFhDnwB8Fqn20onsXMuskoyye4REnSuQrcLT0yRaXnBIhaCGz5gwjDwF+BxwBrI2vABY2ZuacEo+2Ni1I8t3LwIXp0m0seCQmooaPiNs7N6OPJdfAPwRmA8srvPwsVWxsWsDJiM9/rXA3LoU2FDD7yE2dhb4ElJRZjFy8WhedwkI8yqzkDoClwFLq/6opYbvA2HYPhK4GGhHdq39sG671qqCjd2JwNVAf+CraRKtLTik3FDD94JQa30icAnwJjAbWKK529XAxm4MYvwnkf32pSoJtjuo4XeD8Jqlqcia7lrg+7puXk1CMtQkJBnqXmTT0svFRpUdavhdEIZ6U5BXLd0J/EDXzetB2NcwHbnJ/xiYnSbRK8VGteeo4XtgY3cA8BlkFncrUjzxLt2aWk9s7AYBFwLTgJ8gxi9tj6+G53+ztR1IksyJwE+BW9MkejxLHaW89DB+J3BtmkRpoUH1gVoaPjynnYC85+yjwBHAUqS084q6rMkqvSfU/P88shT7GHAzsLws5cYqb/iwhDYEeD+y3noqYvYngBXIxMxDVV9/VbIldBpjkTme4ch11IlkVLas+Sth+LBcNgTpqbvaUcjLCo8E/oxUOF2LvLDwUe3FlawIr9gej2yO+iCySed+4CHgkTSJthQXXXda3vDhBQSHIIY+JJ3VscjOWJqw3diHA3sj6azPA38IbQNi8ud0nVxpFuGlmCcDo5H5oPbwq4eRR4Cnu1qaRJubHV/TDR964/2BAxrau2gwdcPn/sgLEF9CCkS8lM7qOM/OWDqZ7cbeqHXJlVYmrPy0A8cgI8+uNgjppJ4GngNeADY2tC1ZP2r2yvA2dlcDe4XW1vB1V+uPvLxwQGiNXw8K328DtgCbG9omGkzd8Pn/J9wCqbWKkgWh8+t6/LRInYTGNhgwwGuIT7YAbyCd4NauzzSJvrzbot77TBswLetjqk65dKp0LlXTaevjzWlXTMvhmKpTLp0qnUuldPIwvKIoLYoaXlFqRB6Gn5fDMVWnXDpVOpdK6bT8OryiKNmhQ3pFqRH99vQAxpiPIFVaN3nvbzXGTADGee/P2+Podq1zLpIf/3Pv/X056pyBZEyt897fm5dO+NmNwHzv/Zq8dIwxM5H13GXe+6dy1BmNlAFb473/dY46E5AU6n2891fmqDMF2A/Aez8nJ43JSLLZ8977ziw0epJFDz/Se58ABwF47+8G0gyO+1Y6twE3AkPz1AHWIOm7W/PUMcZMRPKvs6bn+bwC7NsEnfFIkkjWpbl3dL09i9T7z00HSSw7GEkSy0vjCO/9bGBchhrdyMLwzZoE6KZjjNkX2am0IE8d7/1mZCtk1jeWnn+3E5CdfKPy1PHezwW+C3wiTx1gUNAak7MOwPHe+/U567R57y8DhuWo8StjzEVIZl0u7PGQHlhjjJkBvGqMGQ4MBEYZY0Z571dlcPyd6VwEPAOcBKzOUacd+SdnNszekY73fqYx5jSyH0n0PJ/3Io9CK3PWWW6MuQTJFc9TZwPwasYaO9IZaIz5CrLzMi+NNiQN/Z4MNbqhs/SKUiN0ll5RaoQaXlFqhBpeUWqEGl5RaoQaXlFqhBpeUWqEGl5RaoQaXlFqhBpeUWqEGl5RaoQaXlFqxH8BJPSS7QzepKIAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0106020M0AAACAC&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Senna 7.5mg tablets : 227</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0106020M0AAAJAJ&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Senna fruit 12.4% / Ispaghula 54.2% granules : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0106020M0AAAPAP&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Senna 15mg tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0106020M0AAATAT&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Senna 7.5mg/5ml oral solution sugar free : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Antimuscarinic drugs</td>
      <td>13</td>
      <td>0.00</td>
      <td>0.82</td>
      <td>0.36</td>
      <td>-2.30</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0703050A0&amp;denomIds=7.3.5&amp;selectedTab=summary">Levonorgestrel</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Emergency contraception</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.62</td>
      <td>0.33</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601012V0&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>33</td>
      <td>Intermediate and long-acting insulins</td>
      <td>381</td>
      <td>0.09</td>
      <td>0.33</td>
      <td>0.13</td>
      <td>-1.83</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601012V0BCABAF&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Toujeo 300units/ml inj 3ml pre-filled DoubleStar pens : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601012V0BBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Lantus 100units/ml solution for injection 3ml cartridges : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601012V0BBAEAD&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Lantus 100units/ml inj 3ml pre-filled SoloStar pens : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0601012V0BCAAAE&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Toujeo 300units/ml inj 1.5ml pre-filled SoloStar pens : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0205052N0&amp;denomIds=2.5.5&amp;selectedTab=summary">Losartan potassium</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>286</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1676</td>
      <td>0.17</td>
      <td>0.50</td>
      <td>0.19</td>
      <td>-1.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0205052N0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 25mg tablets : 43</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0205052N0AAABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 50mg tablets : 123</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0205052N0AAADAD&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 100mg tablets : 113</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0205052N0AAAHAH&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Losartan 12.5mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C87029&amp;numIds=0205052N0BBABAB&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Cozaar 50mg tablets : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>